about usmain logo

A New Era in Targeted Anti-Viral Therapeutics

Imagine coursing through the blood stream, chasing through the body, grabbing and destroying the offending virus particles. NanoViricides, Inc. is striving to bring this imagination to fruition. A nanoviricide®, as defined by the Company, is a nanomachine that is armed to destroy a particular kind of virus. Which virus? That information is programmed into the nanoviricide, akin to the postal address on an envelope.

Biomimetic Technology to "Fool" Viruses

A "nanoviricide" is an agent designed by the Company to fool a virus into attaching to this antiviral nanomachine, in the same way that the virus normally attaches to the receptors on a cell surface. Once attached, the flexible nanoviricide glob wraps around the virus and traps it. In the process, the virus also loses its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. A nanoviricide completes the task of dismantling the virus particle without immune system assistance. This is the putative or designed mechanism of action of a nanoviricide. Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines), which are currently well established antiviral strategies.more....

NanoViricides In the News

08-21-2018Uptick Newswire's "Stock Day" Podcast
By - Uptick Newswire
08-24-2016Shelton company sets sites on fighting disease
By - CT Post NewsTimes
08-24-2016U.S. Sen. Chris Murphy Tours Shelton Nanotech Company
By - Valley Independent Sentinel

Scientific Presentations and Abstracts

06-26-2018Nanoviricides Prevent Varicella Zoster Virus Infection in Human Skin

06-24-2017Nanoviricides® Highly Effective Against Varicella Zoster Virus in Cell Culture

Dr. Taraporewala is a seasoned pharma executive with over 25 years of experience


Irach B. Taraporewala

Chief Executive Officer and Director

Dr. Diwan invented novel polymeric micelle-based nanomedicine technologies


Anil R. Diwan

Chairman, President

Ms. Vyas was First Indian woman to be named CEO of a publicly listed US corporation


Meeta Vyas

Chief Financial Officer

Dr. Barton has over 25 years experience in drug discovery and development


Randall Barton

Chief Scientific Officer

Contact Information

NanoViricides, Inc.
1 Controls Drive,
Shelton, CT 06484

Phone: +1-203-937-6137
Phone: +1-888-591-3579
Fax: +1-203-859-5095
E-mail: info@nanoviricides.com